Biotechnology company RubrYc Therapeutics, Inc., founded in 2017, has developed a proprietary machine learning-driven solution for the discovery of best-in-class and first-in-class epitope ...

Springer Nature offers agreements that enable institutions ... authors retain copyright of their articles. Cell Death Discovery articles are published OA under a CC BY license (Creative Commons ...

Nature Reviews Drug Discovery is a review journal with an emphasis on drug discovery and development. With an impact factor of 28.712 in 2010 it is the leading journal in pharmacology/pharmacy and ...

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

In a new study published in Nature Communications, a team at Osaka University has developed a technology that streamlines ...

Newly discovered 1.5-million-year-old footprints reveal how two extinct human species crossed paths within hours of each ...